Sanofi and Verily (Google Life Sciences) are the latest pharma/tech partnership in what’s being called the “Internet of Medical Things” (IoMT). Their joint venture, Onduo, will combine Sanofi’s experience in diabetes treatment with Verily’s reputation for consumer software, analytics, and miniature electronics. The IoMT market was $32.4 billion in 2015, but is projected to reach $163.2 billion by 2020. Other pharma/tech partnerships include: Pfizer and IBM teaming up to collect data from Parkinson’s patients, Novartis and Qualcomm collaborating on biometrics, and a host of other joint ventures related to smart pill bottles, smart inhalers, etc. The first Onduo products (TBD on specifics) are expected to launch in 2018.